Caitlin M. Murphey

Biography

Caitlin Murphey advises public and private companies across a wide range of sophisticated corporate, transactional, and securities matters, including SEC reporting and compliance, public and private offerings, exchange listings, mergers and acquisitions, corporate governance, and strategic business transactions.

Caitlin has extensive experience representing public companies in their Securities Act and Exchange Act reporting obligations, including the preparation and filing of current and periodic reports, proxy statements, registration statements, prospectuses, Section 16 filings, and Schedule 13D/G filings. She regularly works with executive teams, in-house counsel, and boards of directors to navigate complex regulatory frameworks, implement corporate best practices, and manage risk and governance processes.

Her practice includes representing issuers, underwriters, and placement agents in initial public offerings, registered and private offerings, at-the-market and confidentially marketed transactions, Regulation A+ offerings, and cross-border financings. Caitlin also advises private companies on securities offerings and related transaction documents, including private placement memoranda, subscription agreements, and side letters.

In addition, Caitlin counsels clients through acquisitions, divestitures, and other strategic business combinations, guiding them through due diligence, negotiation of term sheets and transaction documents, coordination with specialist teams, and management of deal execution and closings. She also prepares and reviews a wide range of commercial and corporate agreements, including NDAs, employment and equity agreements, license agreements, commercial contracts, and other operational contracts.

Prior to joining the firm, Caitlin practiced at national and regional law firms and served as in-house counsel at a large insurance and financial services organization, supporting corporate transactions and advising executive leadership on both legal and business issues.

While in law school, Caitlin served as comment editor for the San Diego Law Review and was a member of Phi Delta Phi International Legal Honor Society.

Experience

Represented a clean energy software solutions company in its registered at-the-market offering of up to $500 million.
Represented a private real estate development company in connection with multiple real estate syndications, raising approximately $150 million.
Represented a therapeutics company in its up to $75 million tranched private offering of preferred stock and warrants.
Represented a diagnostic healthcare provider in connection with its implement ation of three equity line arrangements, with an aggregate value of $50 million.
Represented a Silicon Valley-based bioelectronic medicine company in its successful $17.25 million IPO and concurrent Nasdaq listing.
Represented an e-sports gaming company in its successful $25.0 million IPO and concurrent Nasdaq listing.
Represented a Nasdaq-listed e-commerce and digital marketing company in its $10.2 million private offering of preferred stock and warrants.
Represented a biometric solutions company in a $10.0 million private placement and concurrent debt exchange.
Represented an OTCQB-listed oncology company in a continuous $20.0 million Regulation A+ offering.
Represented a Nasdaq-listed medical device company in a series of tranched shelf financings.
Represented a Nasdaq-listed biotech issuer in a series of tranched shelf financings.
Represented a Nasdaq-listed emerging technologies company in its $30 million registered direct public offering of common stock and warrants.
Represented a Nasdaq-listed pharmaceutical modeling and simulation software company in its $100 million acquisition of a private equity backed target.
Represented a Nasdaq-listed pharmaceutical modeling and simulation software company in its approximately $22 million acquisition of private target.
Represented a Nasdaq-listed therapeutics company in its $16.3 million acquisition of assets in a public sale pursuant to Article 9 of the UCC.
Represented a travel booking platform company in its $40 million reverse merger into Nasdaq issuer.